Delivery Order SPE2DR25D6028-SPE2DR26FATCC
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 8, 2025, for the supply of Spironolactone 50 mg tablets in quantities of 500 units. The contract is valued at $1,158.42 with a firm fixed price structure and an ultimate completion date of July 9, 2025. This award was competitively awarded with no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Spironolactone 100-count units under contract number 4568856471. This firm fixed-price delivery order carries a ceiling value of $1,855.59 and is scheduled for completion by August 18, 2025. The award represents a non-set-aside, competitively awarded procurement processed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,715.11 firm fixed-price delivery order is for the supply of 4557842237 - Spironolactone 100 mg Tablets, 100 per bottle. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which covers a wide range of pharmaceutical products...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,623,879 units of Spironolactone 50 mg tablets. The contract has a Firm Fixed Price of $3,864.12 and an ultimate completion date of January 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a for-profit organization. The contract is not designated...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,523.58 firm fixed-price delivery order contract is for the supply of 4,561,272,132 units of 50 mg Spironolactone tablets. The contract has an ultimate completion date of June 20, 2023 and is not associated with a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,056.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 100 milligram Spironolactone tablets. The order is to be delivered from Amerisourcebergen's Conshohocken, Pennsylvania facility by June 22, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under an existing indefinite-delivery/indefinite-quantity contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,928.86 order is for the delivery of 500 units of Spironolactone 50 mg tablets by December 22, 2023. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. The company has received numerous federal contracts from DLA to...
- The Defense Logistics Agency awarded a $241,980 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 bottles containing 100 spironolactone tablets each. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 21, 2023. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.09 firm fixed-price delivery order is for the supply of 4,564,961,020 units of Spironolactone 50 mg tablets. The award has a completion date of June 21, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,970.63 for the supply of Spironolactone 50 mg Tablets in quantities of 100s. The contract has an ultimate completion date of November 21, 2023. The contract is not designated as a set-aside. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATCCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Spironolactone 100mg tablets under a firm fixed-price arrangement. The contract, valued at $1,592.36, was competitively awarded without a set-aside designation and carries an ultimate completion date of January 22, 2026. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters operations. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated capability to fulfill federal requirements through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/22/25 |